Amyloid Imaging PET Ligands as Biomarkers for Alzheimer’s Disease, Preclinical Evaluation

QR Code

Amyloid Imaging PET Ligands as Biomarkers for Alzheimer’s Disease, Preclinical Evaluation

None

Saved in:

Bibliographic Details
Main Authors:	Svedberg, Marie, Hellström-Lindahl, Ewa, Rahman, Obaidur, Hall, Håkan
Format:	Electronic Book Chapter
Language:	English
Published:	IntechOpen 2012
Subjects:	Health Sciences
Online Access:	https://www.intechopen.com/chapters/27818
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Diagnostic Challenge in Frontal Variant Alzheimer's Disease With Low Amyloid‐β PET Retention
by: Ryosuke Shimasaki, et al.
Published: (2025-07-01)

Understanding the impact of amyloid beta targeted therapies on biomarkers and clinical endpoints in Alzheimer's disease
by: Ronald C. Petersen, et al.
Published: (2025-04-01)

Image quality evaluation for two different positron emitters in a preclinical PET scanner
by: Rodrigo Modesto Gadelha, et al.
Published: (2020-09-01)

The Clinical Use of SPECT and PET Molecular Imaging in Alzheimer’s Disease
by: Valotassiou, Varvara, et al.
Published: (2011)

Spatial resolution of a preclinical PET tomograph
by: Guilherme Cavalcante de Albuquerque Souza, et al.
Published: (2021-04-01)

Task-Related EEG as a Biomarker for Preclinical Alzheimer’s Disease: An Explainable Deep Learning Approach
by: Ziyang Li, et al.
Published: (2025-07-01)

Tau and Amyloid- Conformational Change to  -Sheet Structures as Effectors in the Development of Alzheimer's Disease
by: Anda-Hernández, Martha A. De, et al.
Published: (2012)

Anti-amyloid Monoclonal Antibodies for Alzheimer’s Disease: A New Hope? (Review)
by: I. A. Mazerkina
Published: (2025-04-01)

A novel view on Alzheimer’s disease pathogenesis: modern conceptof amyloid clearance
by: V. Yu. Lobzin, et al.
Published: (2018-11-01)

Animal models of Alzheimer’s disease: preclinical insights and challenges
by: Qing-Qing Xu, et al.
Published: (2023-05-01)

Diagnostic value of fluid‐based non‐amyloid biomarkers for Alzheimer's disease and related dementias in a clinic‐based cohort from South Asia
by: Faheem Arshad, et al.
Published: (2025-04-01)

Consistency Analysis of Centiloid Values Across Three Commercial Software Platforms for Amyloid PET Quantification
by: Hyukjin Yoon, et al.
Published: (2025-06-01)

Estimating the optimal cutoff for the IGT‐AD Distress subscale adapted for amyloid PET results disclosure
by: Dianxu Ren, et al.
Published: (2025-04-01)

The Efficacy of Anti-amyloid Monoclonal Antibodies in Early Alzheimer’s Dementia: A Systematic Review
by: Alyaa Mostafa, et al.
Published: (2025-05-01)

Mannose Promotes β‐Amyloid Pathology by Regulating BACE1 Glycosylation in Alzheimer's Disease
by: Chensi Liang, et al.
Published: (2025-03-01)

Role of neuronal fabp in autophagy and amyloid-β pathology in a Drosophila model of Alzheimer disease
by: Byoungyun Choi, et al.
Published: (2025-12-01)

PET Imaging of Gliomas
by: Bansal, Aditya, et al.
Published: (2011)

Amyloid-beta 40 as a biomarker of cognitive impairment in acute ischemic stroke
by: Aleksey A. Kulesh, et al.
Published: (2017-10-01)

Effects of PET image reconstruction parameters and tumor-to-background uptake ratio on quantification of PET images from PET/MRI and PET/CT systems
by: Amena Ali Hussain, et al.
Published: (2024-09-01)

Systematic search for peptide and protein ligands of human serum albumin capable of affecting its interaction with amyloid β peptide
by: E. V. Loktyushov, et al.
Published: (2022-12-01)

Comparative Safety Profiles of Anti-Amyloid Therapies in Early Alzheimer’s Disease (AD): A Detailed Systematic Review and Meta-Regression Analysis of Amyloid Related Imaging Abnormalities (ARIA) – Incidence and Infusion Reactions for Lecanemab, Donanemab, and Aducanumab
by: Sathyan Soundara Rajan, et al.
Published: (2025-06-01)

Solving the Amyloid Paradox: Unveiling the Complex Pathogenicity of Amyloid Fibrils
by: Maksim I. Sulatsky, et al.
Published: (2025-07-01)

Image quality evaluation of a small animal PET scanner
by: Andréa Vidal Ferreira, et al.
Published: (2020-03-01)

Development and preclinical characterization of AMG 329: a human antibody neutralizing FLT3 ligand
by: Annie Lau-Kilby, et al.
Published: (2025-12-01)

PET Imaging in Gastric Carcinoma
by: Kamimura, Kiyohisa, et al.
Published: (2011)

Free Software for PET Imaging
by: Prieta, Roberto de la
Published: (2012)

Efficacy and safety of passive immunotherapies targeting amyloid beta in Alzheimer's disease: A systematic review and meta-analysis.
by: Reina Tonegawa-Kuji, et al.
Published: (2025-03-01)

Nose-to-brain delivery of targeted lipid nanoparticles as two-pronged β-amyloid nanoscavenger for Alzheimer's disease therapy
by: Yanyan Xu, et al.
Published: (2025-06-01)

Prevalence of cerebral amyloid angiopathy and its correlation with Alzheimer's disease and cognition in an autopsy‐confirmed cohort from China
by: Xiang‐Sha Yin, et al.
Published: (2025-04-01)

Relationship between tau-PET and quantitative susceptibility mapping in atypical Alzheimer’s disease
by: Neha Singh-Reilly, et al.
Published: (2025-07-01)

Alzheimer’s Diseases: Towards Biomarkers for an Early Diagnosis
by: Elmoualij, Benaïssa, et al.
Published: (2011)

Amyloid tumor of the breast
by: Makiko Mori, et al.
Published: (2019-02-01)

Predicting amyloid status in mild cognitive impairment: the role of semantic intrusions combined with plasma biomarkers
by: Yao Lu, et al.
Published: (2025-06-01)

Recent Preclinical Evidence on Phytocannabinoids in Neurodegenerative Disorders: A Focus on Parkinson’s and Alzheimer’s Disease
by: Nicoleta-Mirela Blebea, et al.
Published: (2025-06-01)

Cerebrospinal fluid β-amyloid1-42 levels in the differential diagnosis of Alzheimer's disease--systematic review and meta-analysis.
by: Jin-A Mo, et al.
Published: (2015-01-01)

PET and SPECT Imaging of Tumor Angiogenesis
by: Dort, Marcian E. Van, et al.
Published: (2012)

Oxidative Stress in Alzheimer’s Disease: Pathogenesis, Biomarkers and Therapy
by: Gella, Alejandro, et al.
Published: (2011)

Blood‐based biomarkers of Alzheimer's disease: Standardization and comprehensiveness
by: Ying Liu, et al.
Published: (2024-12-01)

Use of Model‐Based Meta‐Analysis to Inform the Design of Early Clinical Trials of Anti‐Amyloid Beta Therapies in Alzheimer's Disease
by: Sagar S. Bachhav, et al.
Published: (2025-07-01)

Amyloid cardiomyopathy: сlinical significance and diagnostic value of magnetic resonance imaging
by: M. V. Ezhikova, et al.
Published: (2024-11-01)